High-dose daunorubicin therapy for acute nonlymphocytic leukemia: Correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity
- 1 December 1972
- Vol. 30 (6), 1419-1427
- https://doi.org/10.1002/1097-0142(197212)30:6<1419::aid-cncr2820300602>3.0.co;2-i
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Daunorubicin metabolism: estimation of daunorubicin reductaseBritish Journal of Pharmacology, 1971
- L-Asparaginase: Clinical, Biochemical, Pharmacological, and Immunological StudiesAnnals of Internal Medicine, 1971
- THE TREATMENT OF ACUTE MYELOBLASTIC LEUKAEMIABritish Journal of Haematology, 1971
- Empiric Therapy with Carbenicillin and Gentamicin for Febrile Patients with Cancer and GranulocytopeniaNew England Journal of Medicine, 1971
- The pharmacokinetics of daunomycin in manClinical Pharmacology & Therapeutics, 1971
- FACTORS EFFECTING REMISSION AND SURVIVAL IN ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)Medicine, 1970
- Treatment of adult acute leukemia with arabinosylcytosine and thioguanineCancer, 1969
- DAUNORUBICIN IN THE TREATMENT OF ACUTE MYELOCYTIC LEUKÆMIAThe Lancet, 1969
- Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemiaCancer, 1967
- Effect of platelet transfusion on hemorrhage in patients with acute leukemia: An autopsy studyCancer, 1966